a company which engages in the business of developing and commercializing novel therapies for fibrotic diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To PLRX | 1D Price Change % | ||
---|---|---|---|---|
PLRX | 100% | -0.36% | ||
NTLA - PLRX | 52% Loosely correlated | -3.24% | ||
BEAM - PLRX | 50% Loosely correlated | -1.57% | ||
INZY - PLRX | 49% Loosely correlated | -5.59% | ||
RCKT - PLRX | 49% Loosely correlated | -2.25% | ||
ABSI - PLRX | 49% Loosely correlated | -13.74% | ||
More |
Ticker / NAME | Correlation To PLRX | 1D Price Change % |
---|---|---|
PLRX | 100% | -0.36% |
novel therapies theme (2 stocks) | 91% Closely correlated | -5.06% |
therapeutics theme (53 stocks) | 48% Loosely correlated | -2.44% |